FDA product code GGX: Pipette, Sahli

GGX is the FDA product code for pipette, sahli. It is a Class I device, regulated under 21 CFR 864.6160 and reviewed by the Hematology panel. FDA has cleared 2 510(k) submissions under GGX, from 2 different applicants. The average 510(k) review took 75 days (median 75).

Classification

FieldValue
Device namePipette, Sahli
Device classClass I
Regulation21 CFR 864.6160
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every GGX clearance

Top GGX applicants

ApplicantClearancesLatest
Trimedyne, Inc.11990-07-23
Catachem, Inc.11989-10-12

Most recent GGX clearances

510(k)ApplicantDeviceDecision dateReview days
K902263Trimedyne, Inc.OPTILASE MODEL 1000 ND:YAG LASER ADD'L INDICATION1990-07-2363
K894389Catachem, Inc.CREATININE FOR MANUAL OR AUTOMATED APPLICATIONS1989-10-1287

Recalls for GGX devices

openFDA lists no recalls for product code GGX.

Frequently asked questions

What is FDA product code GGX?

GGX is the FDA product code for pipette, sahli. It is a Class I device, regulated under 21 CFR 864.6160 and reviewed by the Hematology panel.

What device class is GGX?

Class I, regulation 21 CFR 864.6160. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code GGX?

Across 2 cleared submissions the average was 75 days from receipt to decision (median 75).

Which companies have the most GGX clearances?

Trimedyne, Inc. (1); Catachem, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times